Unknown

Dataset Information

M6A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes.


ABSTRACT:

Background

Meningiomas are the most common primary intracranial tumors in adults. According to the 2021 World Health Organization (WHO) classification of central nervous system tumors, approximately 80% of meningiomas are WHO grade 1, that is, histopathologically benign, whereas about 20% are WHO grade 2 or grade 3, showing signs of atypia or malignancy. The dysregulation of N6-methylation (m6A) regulators is associated with disorders of diverse critical biological processes in human cancer. This study aimed to explore whether m6A regulator expression was associated with meningioma molecular subtypes and immune infiltration.

Methods

We evaluated the m6A modification patterns of 160 meningioma samples based on 19 m6A regulators and

SUBMITTER: Chen J 

PROVIDER: S-EPMC8727752 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature